First-line chemotherapy with planned sequential administration of gemcitabine (G) followed by docetaxel (D) in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study

被引：0
|
作者：
Vasile, E.
Tibaldi, C.
Antonuzzo, A.
Di Marsico, R.
Tartarelli, G.
Fabbri, A.
Lo Dico, M.
Mazzoni, E.
Andreuccetti, M.
Falcone, A.
机构：
[1] Civil Hosp, Div Med Oncol, Livorno, Italy
[2] Civil Hosp, Div Med Oncol, Piombino, Italy
[3] Civil Hosp, Div Med Oncol, Cecina, Italy
[4] Civil Hosp, Div Med Oncol, Viareggio, Italy
[5] Civil Hosp, Div Pneumol, Pistoia, Italy
[6] Univ Pisa, ITT Ist Toscano Tumori, Pisa, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19092
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II study of biweekly Gemcitabine and Docetaxel as first line treatment for advanced disease in elderly Non Small Cell Lung Cancer (NSCLC) patients
    Munoz-Langa, Jose
    Sanchez-Hernandez, Alfredo
    Gomez-Codina, Jose
    Esquerdo, Gaspar
    Catot, Silvia
    Macia, Sonia
    Juan, Oscar
    Giner, Vicente
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S700 - S701
  • [22] Phase II study of docetaxel monotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC)
    Takigawa, N
    Segawa, Y
    Kishino, D
    Fujiwara, K
    Shinkai, T
    Watanabe, Y
    Tabata, M
    Kiura, K
    Ueoka, H
    Tanimoto, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 776S - 776S
  • [23] A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer
    Pallis, AG
    Agelidou, A
    Papakotoulas, P
    Tsaroucha, A
    Agelidou, M
    Agelaki, S
    Androulakis, N
    Vamvakas, L
    Gerogianni, A
    Kotsakis, A
    Kentepozidis, N
    Georgoulias, V
    LUNG CANCER, 2006, 52 (02) : 165 - 171
  • [24] Sequential versus concomitant administration of docetaxel and gemcitabine as first-line treatment of advanced non-small cell lung cancer (NSCLC):: results of a phase II/III randomised study
    Manegold, C.
    Thatcher, N.
    Kortsik, C.
    Koschel, G.
    Spengler, W.
    Mezgar, J.
    Schott von Romer, K.
    Pilz, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 326 - 326
  • [25] A multicenter phase II study of sequential gemcitabine followed by docetaxel in elderly advanced non-small cell lung cancer (NSCLC) patients. From the 'Polmone Toscano Group' (POLTO)
    Vasile, E.
    Tibaldi, C.
    Antonuzzo, A.
    Tartarelli, G.
    Amoroso, D.
    Di Marsico, R.
    Fabbri, A.
    Innocenti, F.
    Chioni, A.
    Nacci, A.
    Ricci, S.
    Andreuccetti, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI23 - XI23
  • [26] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
  • [27] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study
    Joaquín Casal
    Margarita Amenedo
    José Ramón Mel
    Luis Miguel Antón
    Rubén Rodríguez-López
    Rafael López-López
    Ana González-Ageitos
    Javier Castellanos
    Manuel Constenla
    José L. Tisaire
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 725 - 732
  • [28] Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
    D'Addario, G.
    Rauch, D.
    Stupp, R.
    Pless, M.
    Stahel, R.
    Mach, N.
    Jost, L.
    Widmer, L.
    Tapia, C.
    Bihl, M.
    Mayer, M.
    Ribi, K.
    Lerch, S.
    Bubendorf, L.
    Betticher, D. C.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 739 - 745
  • [29] First Line Chemotherapy with Weekly Docetaxel and Cisplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer A Multicenter Phase II Study
    Han, Keqi
    Cao, Weiguo
    Che, Jinfeng
    Bo, Shenxu
    Guo, Xiaodong
    Huang, Guang
    Ma, Lijun
    Sun, Liangqi
    Gao, Chunfang
    Zhong, Baoliang
    Cao, Zhigang
    Tucker, Steven Jay
    Wang, Daoyuan
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 512 - 517
  • [30] Phase II study of gemcitabine (G) in combination with docetaxel (D) in advanced non-small-cell lung cancer (NSCLC) patients.: (Oncopaz and Hospitals Associated).
    García, C
    Milla, A
    Feliu, J
    Lorenzo, A
    Madroñal, C
    Gili, F
    Baena, JM
    ANNALS OF ONCOLOGY, 2000, 11 : 113 - 113
12345